Ground Breaking Technology
Pioneering the Production of Psilocybin
Psychedelic & Functional Mushroom Sales Positioned to Reach $7.2B
In 2022, the U.S. market for functional and psychedelic mushrooms reached a valuation of USD 3.6 billion, with anticipated growth at a CAGR of 12.1% from 2023 to 2030. This upward trajectory aligns with the increasing momentum in the United States toward the decriminalization of not only psychedelic mushrooms but the rapid growth and benefits of functional mushrooms.
$7.2B
Estimated 2030 Market Size
Legal Landscape of the Psychedelic Mushroom Market
In 2022, the U.S. market for functional and psychedelic mushrooms reached a valuation of USD 3.6 billion, with anticipated growth at a CAGR of 12.1% from 2023 to 2030. This upward trajectory aligns with the increasing momentum in the United States toward the decriminalization of not only psychedelic mushrooms but the rapid growth and benefits of functional mushrooms.
Hypha Labs Delivers Measurable Active Ingredients
Hyphalabs has developed technology that quickly cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom’s mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes 6-8 weeks to fully grow mushrooms, and using Hyphalabs technology the production of the active ingredient is only 7-10 days. This natural product solves the dosing issue created by having to use whole mushrooms currently. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits.
Mental and Physical Health Solutions
A rising trend in natural and holistic health practices has emerged, encompassing the utilization of natural substances like psilocybin and functional fungi. As individuals become more aware of the potential side effects and risks associated with pharmaceutical drugs, there appears to be a growing inclination towards alternative treatments, including psychedelics, that peer-reviewed clinical research is showing great promise in treating depression, anxiety, and post-traumatic stress disorder (PTSD). Below are some of the varieties of mushrooms and their benefits:
Psilocybin Mushrooms
(Psilocybe Cubensis)
- 99 Ongoing Clinical Trials
- Depression / Anxiety
- Substance Use Disorder (Addiction)
- Post Traumatic Stress Disorder (PTSD)
Lion's Mane Mushrooms
(Hericium erinaceus):
- May enhance cognitive function and support brain health.
- Contain compounds that stimulate nerve growth.
- Potential to reduce symptoms of anxiety and depression.
Button Mushrooms
(Agaricus bisporus):
- Rich in antioxidants, including Selenium & vitamin C.
- May support the immune system.
- Contain B vitamins, such as riboflavin and niacin.
- May help regulate blood sugar levels.